Abstract:Purpose/Objective(s) The XXXX conducted eight surveys of all operational United States proton centers (2012-2021), analyzing patients treated, diagnoses, treatment complexity, to evaluate trends and diversification of patients receiving proton therapy. Materials/Methods Detailed surveys were sent in 2015, which requested data on 2012-2014, then annually to active proton centers in the US. Patient numbers treated at each center for the preceding calendar year(s) were collated for tumors in the following categories: central nervous system (CNS), intraocular, pituitary, skullbase/skeleton, head/neck, lung, retroperitoneal/soft tissue sarcoma, pediatric (solid tumors in children age ≤18), gastrointestinal tract, urinary tract, female pelvic, prostate, breast and "other." Complexity levels were assessed using CPT codes 77520-77525. Results Survey response rates were excellent (100% in 2015 to 94.9% in 2021); additional publicly available information provided near complete information on all centers. Trend comparisons between 2012 and 2021 showed that the total annual number of patients treated with protons gradually increased from 5,377 to 15,829. The largest numeric increases were for head/neck (316 to 2,303; 7.3-fold), breast (93 to 1,452; 15.6-fold) and gastrointestinal (170 to 1,259; 7.4-fold). Patient numbers also increased significantly for central nervous system (598 to 1,743; 2.9-fold), pediatric (685 to 1,870; 2.7-fold), and skull base (179 to 514; 2.9-fold). For prostate cancer, the percentage of proton-treated patients decreased from 43.4% to 25.0% of the total. Simple compensated treatments decreased from 43% in 2012 to 7% in 2021, whereas intermediate complexity treatments increased from 45% to 73%. Conclusion The number of patients treated with protons is gradually increasing, with a substantial proportionate decline in patients with prostate cancer receiving proton therapy. The number of patients treated for "commonly accepted" indications for protons - pediatric, CNS, and skull base - is gradually increasing. Greater proportional increases were observed for breast, lung, head/neck, and gastrointestinal tumors. Treatment complexity is gradually increasing over time.

Evolving Role of Proton Radiation Therapy in Clinical Practice

Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care

Proton therapy for head and neck cancer: expanding the therapeutic window

The Evolution of Proton Beam Therapy: Current and Future Status (Review)

How proton therapy fits into the management of adult intracranial tumors

Impact of Relative Biologic Effectiveness for Proton Therapy for Head and Neck and Skull-Base Tumors: A Technical and Clinical Review

The status and challenges for prostate SBRT treatments in United States proton therapy centers: An NRG Oncology practice survey

Current Status and Future Directions of Proton Therapy for Head and Neck Carcinoma

Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?

Temporal Evolution and Diagnostic Diversification of Patients Receiving Proton Therapy in the United States: A Ten-Year Trend Analysis (2012-21) from the National Association for Proton Therapy

Proton therapy for locally advanced non-small cell lung cancer

New Frontiers in Proton Therapy: Applications in Cancers.

Proton Therapy in Breast Cancer: A Review of Potential Approaches for Patient Selection

[Current situation and perspectives of proton therapy]

Proton beams in cancer treatments: Clinical outcomes and dosimetric comparisons with photon therapy

Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy

Proton Pencil-Beam Scanning Stereotactic Body Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic Malignancies: Patterns of Practice Survey and Recommendations for Future Development from NRG Oncology and PTCOG

Enabling Clinical Use of Linear Energy Transfer in Proton Therapy for Head and Neck Cancer -- A Review of Implications for Treatment Planning and Adverse Events Study

Proton Therapy: Current Status and Controversies

The expanding role of radiation oncology across the prostate cancer continuum